From: Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma
TIMER | GEPIA | ||||||||
---|---|---|---|---|---|---|---|---|---|
Immune cell | Marker | None | purity | Normal | Cancer | ||||
Spearman’s ρ | P Value | Spearman’s ρ | P Value | Spearman correlation coefficient | P Value | Spearman correlation coefficient | P Value | ||
DC | CD1C | 0.36 | 1.65E-17 | 0.34 | 1.03E-14 | −0.022 | 0.87 | 0.33 | 1.5E-13 |
HLA-DPA1 | 0.23 | 1.64E-07 | 0.20 | 8.47E-06 | |||||
HLA-DPB1 | 0.29 | 8.39E-12 | 0.27 | 8.03E-10 | |||||
HLA-DQB1 | 0.21 | 1.31E-06 | 0.18 | 8.16E-05 | |||||
HLA-DRA | 0.18 | 4.54E-05 | 0.14 | 0.0020 | |||||
ITGAX | 0.24 | 1.63E-08 | 0.22 | 1.10E-06 | |||||
NCR1 | 0.04 | 0.35980601 | 0.01 | 0.8450 | |||||
NRP1 | 0.03 | 0.41981037 | 0.03 | 0.4973 | |||||
cDC1s | CD8A | 0.03 | 0.55316497 | −0.03 | 0.5613 | −0.028 | 0.83 | 0.22 | 1.20E-06 |
CLEC9A | 0.40 | 1.00E-21 | 0.38 | 1.16E-18 | |||||
XCR1 | 0.41 | 2.70E-22 | 0.39 | 7.37E-20 | |||||
cDC2s | CLEC12A | 0.22 | 3.50E-07 | 0.18 | 3.61E-05 | 0.18 | 0.16 | 0.45 | 7.1E-25 |
ESAM | 0.51 | 1.01E-35 | 0.50 | 2.89E-33 | |||||
B cell | CD19 | 0.23 | 1.93E-07 | 0.20 | 5.30E-06 | 0.017 | 9.00E-01 | 0.37 | 8.30E-17 |
FCER2 | 0.40 | 7.97E-21 | 0.38 | 2.18E-18 | |||||
MS4A1 | 0.34 | 6.45E-16 | 0.33 | 2.59E-14 | |||||
SDC1 | 0.07 | 0.0917 | 0.09 | 0.0523 | |||||
Naïve B cell | CD19 | 0.23 | 1.93E-07 | 0.20 | 5.30E-06 | 0.082 | 0.54 | 0.43 | 8.60E-23 |
CD22 | 0.50 | 2.44E-34 | 0.51 | 1.10E-34 | |||||
CD83 | 0.33 | 6.56E-15 | 0.31 | 2.09E-12 | |||||
MS4A1 | 0.34 | 6.45E-16 | 0.33 | 2.59E-14 | |||||
TCL1A | 0.25 | 1.57E-08 | 0.21 | 1.31E-06 | |||||
Plasma B cell | CD38 | 0.04 | 0.3699 | 0.08 | 0.0746 | −0.19 | 0.15 | 0.059 | 0.19 |
TNFRSF17 | 0.04 | 0.4053 | 0.08 | 0.0814 |